• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Al Jalila Foundation offers $2.2M in grants for research in UAE

Al Jalila Foundation offers $2.2M in grants for research in UAE

April 24, 2014
CenterWatch Staff

Al Jalila Foundation, a global philanthropic organization dedicated to transforming lives through medical education and research, is seeking applicants to its fellowship and seed grant programs, which aim to improve healthcare in the United Arab Emirates (UAE) by supporting talented biomedicine academics, through $2.2 million for the two research funding and education programs.

Researchers can apply for seed grants of up to $81,700, to investigate regional health issues through basic science, applied or clinical research projects. The grants are available to all nationalities, provided the research is conducted in the UAE. Applicants should hold positions at local universities, research institutions or clinics, and will be assessed through an international peer review process.

The fellowships are available exclusively to Emirati biomedical professionals, offering them the opportunity to study at world-renowned institutions, with an aim to migrate global best practice to the UAE. Applicants will be considered by the Foundation’s Scientific Advisory Board for a place on a three-month Student Research Elective or year-long Research Training Support program.

Al Jalila Foundation looks to the funding to promote regional research into cancer, cardiovascular diseases, diabetes, obesity and mental health. These five health issues have been identified by the Foundation as a focus for the newly-announced Al Jalila Foundation Research Center, the UAE’s first ever standalone medical research center.

Sehamuddin Galadari, professor of biochemistry and molecular cell biology, and academic and research advisor of Al Jalila Foundation, said, “Our funding will support the brightest local minds in biomedical research to study at leading institutions and develop both personally and academically. Our aim is to develop home-grown leaders with the ability to produce preventative medical research that is relevant to the region, thereby transforming the UAE’s healthcare sector.”

Abdulkareem Al Olama, CEO of Al Jalila Foundation, said, “Providing talented local scientists with the opportunity to study at world-class institutions and contribute toward global scientific research will help to establish the UAE as a medical research center on par with the rest of the world.”

Upcoming Events

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • InputinLights-360x240.png

    Seeking Patient Input Early Helps Ensure Minority Participation in Trials

  • Oncology-360x240.png

    Global Oncology Trial Launches Drop Dramatically During Pandemic, Study Shows

  • Qualification-360x240.png

    Sites and Sponsors Streamlining Qualification Efforts with Technology, Process Revisions

  • New Algorithm Tested and Validated by CSDD Highly Predictive of Patient Burden

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing